CVE-2020-10627

Severity CVSS v4.0:

Pending analysis

Type:

Unavailable / Other

Publication date:

01/12/2021

Last modified:

25/09/2023

Description

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Impact

Vector 3.x

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N CVSS v3.1 Severity and Metrics:

Base Score: 8.10 HIGH
Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Attack Vector (AV): Adjacent
Attack Complexity (AC): Low
Privileges Required (PR): None
User Interaction (UI): None
Scope (S): Unchanged
Confidentiality (C): High
Integrity (I): High
Availability (A): None

Base Score 3.x

8.10

Severity 3.x

HIGH

Vector 2.0

AV:A/AC:L/Au:N/C:P/I:P/A:N CVSS v2.0 Severity and Metrics:

Base Score: 4.80 MEDIUM
Vector: AV:A/AC:L/Au:N/C:P/I:P/A:N

Attack Vector (AV): Adjacent
Attack Complexity (AC): Low
Authentication (Au): None
Confidentiality (C): Physical
Integrity (I): Physical
Availability (A): None

Base Score 2.0

4.80

Severity 2.0

MEDIUM

Vulnerable products and versions

CPE	From	Up to
cpe:2.3:o:insulet:omnipod_insulin_management_system_firmware:-:::::::*
cpe:2.3:h:insulet:omnipod_insulin_management_system:19191:::::::*
cpe:2.3:h:insulet:omnipod_insulin_management_system:40160:::::::*

To consult the complete list of CPE names with products and versions, see this page

CVE-2020-10627

Description

Impact

Vulnerable products and versions

References to Advisories, Solutions, and Tools